Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2006 Filed Jul 5, 2006 16:45 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 231 | $23.47 | $5,421.57 |
DisclosureSEC source: 0000078003-06-000167 · lam1236.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,903 Underlying: Common Stock · 231 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 16:46 UTC |
MEAD DANA GDirector
|
GrantPhantom Stock Units · Derivative | 1,601 | $23.47 | $37,575.47 |
DisclosureSEC source: 0000078003-06-000170 · mea1241.xml · derivative · entry 1 MEAD DANA G · CIK 0001174482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,207 Underlying: Common Stock · 1,601 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 16:46 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 351 | $23.47 | $8,237.97 |
DisclosureSEC source: 0000078003-06-000168 · lev1237.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,199 Underlying: Common Stock · 351 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 16:46 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 185 | $23.47 | $4,341.95 |
DisclosureSEC source: 0000078003-06-000169 · mck1238.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,420 Underlying: Common Stock · 185 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 16:46 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 357 | $23.47 | $8,378.79 |
DisclosureSEC source: 0000078003-06-000171 · she1239.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,534 Underlying: Common Stock · 357 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2006 Filed Jul 5, 2006 16:46 UTC |
STEERE WILLIAM C JRDirector
|
GrantPhantom Stock Units · Derivative | 1,111 | $23.47 | $26,075.17 |
DisclosureSEC source: 0000078003-06-000172 · ste1240.xml · derivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,019 Underlying: Common Stock · 1,111 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash following the reporting person's retirement from the Board of Directors. Read SEC document |
| June 15, 2006 Filed Jun 19, 2006 15:45 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 44 | $23.53 | $1,035.32 |
DisclosureSEC source: 0000078003-06-000139 · can1224.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,339 Underlying: Common Stock · 44 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2006 Filed Jun 19, 2006 15:45 UTC |
FECZKO JOSEPH MVice President
|
GrantPhantom Stock Units SSP · Derivative | 52 | $23.53 | $1,223.56 |
DisclosureSEC source: 0000078003-06-000140 · fec1225.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,915 Underlying: Common Stock · 52 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2006 Filed Jun 19, 2006 15:45 UTC |
KATEN KAREN LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 88 | $23.53 | $2,070.64 |
DisclosureSEC source: 0000078003-06-000141 · kat1226.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,939 Underlying: Common Stock · 88 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2006 Filed Jun 19, 2006 15:45 UTC |
KINDLER JEFFREY BVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 73 | $23.53 | $1,717.69 |
DisclosureSEC source: 0000078003-06-000142 · kin1227.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,327 Underlying: Common Stock · 73 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2006 Filed Jun 19, 2006 15:45 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 217 | $23.53 | $5,106.01 |
DisclosureSEC source: 0000078003-06-000143 · lam1228.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,672 Underlying: Common Stock · 217 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2006 Filed Jun 19, 2006 15:45 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 334 | $23.53 | $7,859.02 |
DisclosureSEC source: 0000078003-06-000144 · lev1229.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,848 Underlying: Common Stock · 334 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2006 Filed Jun 19, 2006 15:46 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 155 | $23.53 | $3,647.15 |
DisclosureSEC source: 0000078003-06-000145 · mck1230.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,235 Underlying: Common Stock · 155 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2006 Filed Jun 19, 2006 15:46 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 334 | $23.53 | $7,859.02 |
DisclosureSEC source: 0000078003-06-000146 · she1231.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,177 Underlying: Common Stock · 334 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2006 Filed Jun 2, 2006 15:49 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 48 | $23.66 | $1,135.68 |
DisclosureSEC source: 0000078003-06-000128 · can1216.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,295 Underlying: Common Stock · 48 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2006 Filed Jun 2, 2006 15:10 UTC |
FECZKO JOSEPH MVice President
|
GrantPhantom Stock Units SSP · Derivative | 67 | $23.66 | $1,585.22 |
DisclosureSEC source: 0000078003-06-000129 · fec1217.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,863 Underlying: Common Stock · 67 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2006 Filed Jun 2, 2006 15:10 UTC |
KATEN KAREN LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 119 | $23.66 | $2,815.54 |
DisclosureSEC source: 0000078003-06-000130 · kat1218.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,851 Underlying: Common Stock · 119 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2006 Filed Jun 2, 2006 15:49 UTC |
KINDLER JEFFREY BVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 80 | $23.66 | $1,892.80 |
DisclosureSEC source: 0000078003-06-000131 · kin1219.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,254 Underlying: Common Stock · 80 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2006 Filed Jun 2, 2006 15:10 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 377 | $23.66 | $8,919.82 |
DisclosureSEC source: 0000078003-06-000133 · lev1221.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,514 Underlying: Common Stock · 377 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2006 Filed Jun 2, 2006 15:10 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 256 | $23.66 | $6,056.96 |
DisclosureSEC source: 0000078003-06-000132 · lam1220.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,455 Underlying: Common Stock · 256 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2006 Filed Jun 2, 2006 15:49 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 231 | $23.66 | $5,465.46 |
DisclosureSEC source: 0000078003-06-000134 · mck1222.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,080 Underlying: Common Stock · 231 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 31, 2006 Filed Jun 2, 2006 15:10 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 395 | $23.66 | $9,345.70 |
DisclosureSEC source: 0000078003-06-000135 · she1223.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,843 Underlying: Common Stock · 395 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 24, 2006 Filed May 25, 2006 15:15 UTC |
KATEN KAREN LVice Chairman
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,052 | $0.00 Strike: $12.42 | $0.00 |
DisclosureSEC source: 0000078003-06-000127 · kat1215.xml · derivative · entry 4 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,052 shares Expires 2006-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in 5 equal annual installments beginning on August 22,1997. Read SEC document |
| May 24, 2006 Filed May 25, 2006 15:15 UTC |
KATEN KAREN LVice Chairman
|
Tax withholdingCommon Stock | 4,169 | $23.99 | $100,014.31 |
DisclosureSEC source: 0000078003-06-000127 · kat1215.xml · nonDerivative · entry 2 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 941,284 Read SEC document |
| May 24, 2006 Filed May 25, 2006 15:15 UTC |
KATEN KAREN LVice Chairman
|
Exercise / conversionCommon Stock | 8,052 | $12.42 | $100,005.84 |
DisclosureSEC source: 0000078003-06-000127 · kat1215.xml · nonDerivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 945,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2006 Filed May 17, 2006 20:33 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 91 | $24.89 | $2,264.99 |
DisclosureSEC source: 0000078003-06-000117 · can1207.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,247 Underlying: Common Stock · 91 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2006 Filed May 17, 2006 20:33 UTC |
FECZKO JOSEPH MVice President
|
GrantPhantom Stock Units SSP · Derivative | 222 | $24.89 | $5,525.58 |
DisclosureSEC source: 0000078003-06-000118 · fec1208.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,796 Underlying: Common Stock · 222 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2006 Filed May 17, 2006 20:33 UTC |
KATEN KAREN LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 461 | $24.89 | $11,474.29 |
DisclosureSEC source: 0000078003-06-000119 · kat1209.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,732 Underlying: Common Stock · 461 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2006 Filed May 17, 2006 20:33 UTC |
KINDLER JEFFREY BVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 158 | $24.89 | $3,932.62 |
DisclosureSEC source: 0000078003-06-000120 · kin1210.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,174 Underlying: Common Stock · 158 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2006 Filed May 17, 2006 20:34 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 643 | $24.89 | $16,004.27 |
DisclosureSEC source: 0000078003-06-000121 · lam1211.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,199 Underlying: Common Stock · 643 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2006 Filed May 17, 2006 20:34 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 800 | $24.89 | $19,912.00 |
DisclosureSEC source: 0000078003-06-000122 · lev1212.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,137 Underlying: Common Stock · 800 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2006 Filed May 17, 2006 20:34 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 1,072 | $24.89 | $26,682.08 |
DisclosureSEC source: 0000078003-06-000123 · mck1213.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,849 Underlying: Common Stock · 1,072 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 15, 2006 Filed May 17, 2006 20:34 UTC |
SHEDLARZ DAVID LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 1,008 | $24.89 | $25,089.12 |
DisclosureSEC source: 0000078003-06-000124 · she1214.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,448 Underlying: Common Stock · 1,008 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 02, 2006 Filed May 2, 2006 21:02 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
SaleCommon Stock | 5,000 | $25.12 | $125,600.00 |
DisclosureSEC source: 0000078003-06-000102 · can1198.xml · nonDerivative · entry 2 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,179 Read SEC document |
| May 02, 2006 Filed May 2, 2006 21:02 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
SaleCommon Stock | 5,416 | $25.14 | $136,158.24 |
DisclosureSEC source: 0000078003-06-000102 · can1198.xml · nonDerivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,179 Read SEC document |
| May 01, 2006 Filed May 2, 2006 21:02 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
OtherPhantom Stock Units SSP · Derivative | 7,348 | $25.12 | $184,581.76 |
DisclosureSEC source: 0000078003-06-000102 · can1198.xml · derivative · entry 5 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,156 Underlying: Common Stock · 7,348 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 01, 2006 Filed May 2, 2006 21:02 UTC |
KATEN KAREN LVice Chairman
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 159,948 | $0.00 Strike: $12.42 | $0.00 |
DisclosureSEC source: 0000078003-06-000104 · kat1205.xml · derivative · entry 4 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,052 Underlying: Common Stock · 159,948 shares Expires 2006-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option became exercisable in 5 equal annual installments beginning on August 22,1997. Read SEC document |
| May 01, 2006 Filed May 2, 2006 21:02 UTC |
KATEN KAREN LVice Chairman
|
SaleCommon Stock | 159,948 | $25.11 | $4,016,294.28 |
DisclosureSEC source: 0000078003-06-000104 · kat1205.xml · nonDerivative · entry 2 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937,401 Read SEC document |
| May 01, 2006 Filed May 2, 2006 21:02 UTC |
KATEN KAREN LVice Chairman
|
Exercise / conversionCommon Stock | 159,948 | $12.42 | $1,986,554.16 |
DisclosureSEC source: 0000078003-06-000104 · kat1205.xml · nonDerivative · entry 1 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,097,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2006 Filed May 2, 2006 21:02 UTC |
STEERE WILLIAM C JRDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 891,948 | $0.00 Strike: $12.42 | $0.00 |
DisclosureSEC source: 0000078003-06-000110 · ste1206.xml · derivative · entry 5 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 891,948 shares Expires 2006-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option became exercisable in 5 equal annual installments beginning on August 22,1997. Read SEC document |
| May 01, 2006 Filed May 2, 2006 21:02 UTC |
STEERE WILLIAM C JRDirector
|
GiftCommon Stock | 100,461 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-06-000110 · ste1206.xml · nonDerivative · entry 3 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,766,300 Read SEC document |
| May 01, 2006 Filed May 2, 2006 21:02 UTC |
STEERE WILLIAM C JRDirector
|
SaleCommon Stock | 977,736 | $25.26 | $24,697,611.36 |
DisclosureSEC source: 0000078003-06-000110 · ste1206.xml · nonDerivative · entry 2 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,866,761 Read SEC document |
| May 01, 2006 Filed May 2, 2006 21:02 UTC |
STEERE WILLIAM C JRDirector
|
Exercise / conversionCommon Stock | 891,948 | $12.42 | $11,077,994.16 |
DisclosureSEC source: 0000078003-06-000110 · ste1206.xml · nonDerivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,844,497 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2006 Filed May 2, 2006 21:02 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhantom Stock Units SSP · Derivative | 97 | $25.33 | $2,457.01 |
DisclosureSEC source: 0000078003-06-000102 · can1198.xml · derivative · entry 4 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,504 Underlying: Common Stock · 97 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and, subject to certain conditions, may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 28, 2006 Filed May 2, 2006 21:02 UTC |
FECZKO JOSEPH MVice President
|
GrantPhantom Stock Units SSP · Derivative | 14 | $25.33 | $354.62 |
DisclosureSEC source: 0000078003-06-000103 · fec1199.xml · derivative · entry 1 FECZKO JOSEPH M · CIK 0001319874 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,574 Underlying: Common Stock · 14 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| April 28, 2006 Filed May 2, 2006 21:02 UTC |
KATEN KAREN LVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 89 | $25.33 | $2,254.37 |
DisclosureSEC source: 0000078003-06-000104 · kat1205.xml · derivative · entry 5 KATEN KAREN L · CIK 0001174451 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,271 Underlying: Common Stock · 89 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| April 28, 2006 Filed May 2, 2006 21:02 UTC |
KINDLER JEFFREY BVice Chairman
|
GrantPhantom Stock Units SSP · Derivative | 70 | $25.33 | $1,773.10 |
DisclosureSEC source: 0000078003-06-000105 · kin1201.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,016 Underlying: Common Stock · 70 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| April 28, 2006 Filed May 2, 2006 21:02 UTC |
LEVIN ALAN GSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 317 | $25.33 | $8,029.61 |
DisclosureSEC source: 0000078003-06-000107 · lev1202.xml · derivative · entry 1 LEVIN ALAN G · CIK 0001174452 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,337 Underlying: Common Stock · 317 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| April 28, 2006 Filed May 2, 2006 21:02 UTC |
LAMATTINA JOHN LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 207 | $25.33 | $5,243.31 |
DisclosureSEC source: 0000078003-06-000106 · lam1200.xml · derivative · entry 1 LAMATTINA JOHN L · CIK 0001216074 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,556 Underlying: Common Stock · 207 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| April 28, 2006 Filed May 2, 2006 21:02 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 163 | $25.33 | $4,128.79 |
DisclosureSEC source: 0000078003-06-000108 · mck1203.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,777 Underlying: Common Stock · 163 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.